论文部分内容阅读
目的:探讨保乳术联合新辅助化疗对乳腺癌的临床疗效。方法:抽取至我院就诊的40例乳腺癌患者(2012年1月-2017年6月),其中一组采取传统保乳术治疗,另外一组采取新辅助化疗后保乳,对比两组治疗效果。结果:实验组与常规组的治疗优良率分别为70.00%与50.00%,P<0.05;实验组的手术耗时、拔管时间相比常规组均明显较短,实验组的插管引流量明显少于常规组,P<0.05。结论:对乳腺癌患者给予保乳术联合新辅助化疗方案利于缩短手术治疗时间,提高临床治疗效果。
Objective: To investigate the effect of conservative surgery and neoadjuvant chemotherapy on breast cancer. Methods: Forty breast cancer patients (Jan. 2012-Jun. 2017) were selected for treatment in our hospital. One group was treated with traditional breast-conserving surgery and the other group was treated with neoadjuvant chemotherapy. Compared with the two groups, effect. Results: The excellent and good rates of experimental group and conventional group were 70.00% and 50.00%, respectively, P <0.05. The operation time and extubation time in the experimental group were significantly shorter than those in the conventional group, and the intubation and drainage rates in the experimental group were significantly Less than the conventional group, P <0.05. Conclusion: The breast-conserving surgery combined with neoadjuvant chemotherapy regimen will help to shorten the operation time and improve the clinical effect.